Attached files

file filename
EX-32.2 - EX-32.2 - NUTRI SYSTEM INC /DE/ntri-ex322_8.htm
EX-32.1 - EX-32.1 - NUTRI SYSTEM INC /DE/ntri-ex321_7.htm
EX-31.2 - EX-31.2 - NUTRI SYSTEM INC /DE/ntri-ex312_6.htm
EX-31.1 - EX-31.1 - NUTRI SYSTEM INC /DE/ntri-ex311_9.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2017

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From _________ to _________

Commission File Number 0-28551

 

Nutrisystem, Inc.

(Exact name of Registrant as specified in its charter)

 

Delaware

23-3012204

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

 

Fort Washington Executive Center

 

600 Office Center Drive

 

Fort Washington, Pennsylvania

19034

(Address of principal executive offices)

(Zip code)

 

(215) 706-5300

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).    Yes      No  

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer (Do not check if a smaller reporting company)

 

Smaller reporting company

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act    

Indicate by check mark whether the Registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes      No  

Indicate the number of shares outstanding of each of the issuer's classes of common stock as of October 24, 2017:

 

Common Stock, $.001 par value

 

30,039,432 shares

 

 

 


NUTRISYSTEM, INC. AND SUBSIDIARIES

INDEX TO FORM 10-Q

 

 

 

Page

 

 

 

PART I - FINANCIAL INFORMATION

 

 

 

 

 

Item 1 – Financial Statements (unaudited)

 

 

 

 

 

Consolidated Balance Sheets

 

3

 

 

 

Consolidated Statements of Operations

 

4

 

 

 

Consolidated Statements of Comprehensive Income

 

5

 

 

 

Consolidated Statement of Stockholders’ Equity

 

6

 

 

 

Consolidated Statements of Cash Flows

 

7

 

 

 

Notes to Consolidated Financial Statements

 

8

 

 

 

Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations

 

17

 

 

 

 

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

 

23

 

 

 

 

Item 4 – Controls and Procedures

 

23

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

 

Item 1 – Legal Proceedings

 

24

 

 

 

Item 1A – Risk Factors

 

24

 

 

 

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

 

24

 

 

 

Item 3 – Defaults Upon Senior Securities

 

24

 

 

 

Item 4 – Mine Safety Disclosures

 

24

 

 

 

Item 5 – Other Information

 

24

 

 

 

Item 6 – Exhibits

 

25

 

 

 

SIGNATURES

 

26

 

 

 

 

 

 


NUTRISYSTEM, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands, except par value amounts)

 

 

 

September 30,

 

 

December 31,

 

 

 

2017

 

 

2016

 

ASSETS

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

47,648

 

 

$

9,623

 

Short term investments

 

 

41,968

 

 

 

23,873

 

Receivables

 

 

18,898

 

 

 

17,560

 

Inventories

 

 

23,834

 

 

 

38,504

 

Prepaid income taxes

 

 

1,826

 

 

 

0

 

Other current assets

 

 

7,075

 

 

 

10,084

 

Total current assets

 

 

141,249

 

 

 

99,644

 

FIXED ASSETS, net

 

 

31,339

 

 

 

32,643

 

INTANGIBLE ASSETS, net

 

 

13,334

 

 

 

14,084

 

DEFERRED INCOME TAXES

 

 

7,932

 

 

 

6,940

 

OTHER ASSETS

 

 

993

 

 

 

929

 

Total assets

 

$

194,847

 

 

$

154,240

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

 

Accounts payable

 

$

33,682

 

 

$

33,106

 

Accrued payroll and related benefits

 

 

9,978

 

 

 

10,351

 

Income taxes payable

 

 

0

 

 

 

228

 

Deferred revenue

 

 

9,373

 

 

 

7,482

 

Other accrued expenses and current liabilities

 

 

6,300

 

 

 

6,672

 

Total current liabilities

 

 

59,333

 

 

 

57,839

 

NON-CURRENT LIABILITIES

 

 

1,865

 

 

 

1,877

 

Total liabilities

 

 

61,198

 

 

 

59,716

 

COMMITMENTS AND CONTINGENCIES (Note 7)

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

 

 

 

Preferred stock, $.001 par value (5,000 shares authorized, no shares issued and

   outstanding)

 

 

0

 

 

 

0

 

Common stock, $.001 par value (100,000 shares authorized; shares issued – 30,591

   at September 30, 2017 and 30,203 at December 31, 2016)

 

 

30

 

 

 

30

 

Additional paid-in capital

 

 

66,100

 

 

 

54,057

 

Treasury stock, at cost, 551 shares at September 30, 2017 and 517 shares at

   December 31, 2016

 

 

(9,925

)

 

 

(8,329

)

Retained earnings

 

 

77,473

 

 

 

48,799

 

Accumulated other comprehensive loss

 

 

(29

)

 

 

(33

)

Total stockholders’ equity

 

 

133,649

 

 

 

94,524

 

Total liabilities and stockholders’ equity

 

$

194,847

 

 

$

154,240

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

3


NUTRISYSTEM, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in thousands, except per share amounts)

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

REVENUE

 

$

158,149

 

 

$

124,571

 

 

$

565,720

 

 

$

436,504

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COSTS AND EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

72,357

 

 

 

57,694

 

 

 

259,684

 

 

 

205,394

 

Marketing

 

 

42,067

 

 

 

33,499

 

 

 

168,585

 

 

 

128,441

 

General and administrative

 

 

18,626

 

 

 

16,707

 

 

 

59,620

 

 

 

51,744

 

Depreciation and amortization

 

 

3,755

 

 

 

4,332

 

 

 

11,321

 

 

 

10,160

 

Total costs and expenses

 

 

136,805

 

 

 

112,232

 

 

 

499,210

 

 

 

395,739

 

Operating income

 

 

21,344

 

 

 

12,339

 

 

 

66,510

 

 

 

40,765

 

INTEREST (INCOME) EXPENSE, net

 

 

(48

)

 

 

(11

)

 

 

(74

)

 

 

23

 

Income before income tax expense

 

 

21,392

 

 

 

12,350

 

 

 

66,584

 

 

 

40,742

 

INCOME TAX EXPENSE

 

 

6,365

 

 

 

4,401

 

 

 

19,638

 

 

 

14,123

 

Net income

 

$

15,027

 

 

$

7,949

 

 

$

46,946

 

 

$

26,619

 

BASIC INCOME PER COMMON SHARE

 

$

0.50

 

 

$

0.27

 

 

$

1.57

 

 

$

0.90

 

DILUTED INCOME PER COMMON SHARE

 

$

0.49

 

 

$

0.27

 

 

$

1.54

 

 

$

0.90

 

WEIGHTED AVERAGE SHARES OUTSTANDING:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

29,799

 

 

 

29,320

 

 

 

29,685

 

 

 

29,162

 

Diluted

 

 

30,299

 

 

 

29,613

 

 

 

30,164

 

 

 

29,465

 

DIVIDENDS DECLARED PER COMMON SHARE

 

$

0.175

 

 

$

0.175

 

 

$

0.525

 

 

$

0.525

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

4


NUTRISYSTEM, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited, in thousands)

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Net income

 

$

15,027

 

 

$

7,949

 

 

$

46,946

 

 

$

26,619

 

OTHER COMPREHENSIVE INCOME:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized (loss) gain, net of income tax (benefit) expense

    of ($6), ($20), $1 and $28, respectively

 

 

(10

)

 

 

(35

)

 

 

4

 

 

 

52

 

Comprehensive income

 

$

15,017

 

 

$

7,914

 

 

$

46,950

 

 

$

26,671

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

5


NUTRISYSTEM, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

(Unaudited, in thousands)

 

 

 

Common Shares

 

 

Common Stock

 

 

Additional Paid-in Capital

 

 

Treasury Stock

 

 

Retained Earnings

 

 

Accumulated Other

Comprehensive Loss

 

 

Total

 

BALANCE, January 1, 2017

 

 

30,203

 

 

$

30

 

 

$

54,057

 

 

$

(8,329

)

 

$

48,799

 

 

$

(33

)

 

$

94,524

 

Net income

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

46,946

 

 

 

0

 

 

 

46,946

 

Share-based compensation expense

 

 

178

 

 

 

0

 

 

 

7,899

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

7,899

 

Exercise of stock options

 

 

261

 

 

 

0

 

 

 

4,144

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

4,144

 

Purchase and retirement of common shares

 

 

(51

)

 

 

0

 

 

 

0

 

 

 

0

 

 

 

(2,285

)

 

 

0

 

 

 

(2,285

)

Cash dividends

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

(15,987

)

 

 

0

 

 

 

(15,987

)

Employee tax withholdings related to the

   vesting of equity awards

 

 

0

 

 

 

0

 

 

 

0

 

 

 

(1,596

)

 

 

0

 

 

 

0

 

 

 

(1,596

)

Other comprehensive income, net of tax

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

 

 

4

 

 

 

4

 

BALANCE, September 30, 2017

 

 

30,591

 

 

$

30

 

 

$

66,100

 

 

$

(9,925

)

 

$

77,473

 

 

$

(29

)

 

$

133,649

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

6


NUTRISYSTEM, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

 

 

 

Nine Months Ended September 30,

 

 

 

2017

 

 

2016

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

Net income

 

$

46,946

 

 

$

26,619

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

11,321

 

 

 

10,160

 

Loss on disposal of fixed assets

 

 

0

 

 

 

104

 

Share–based compensation expense

 

 

7,899

 

 

 

5,134

 

Deferred income tax (benefit) expense

 

 

(1,015

)

 

 

1,609

 

Other charges

 

 

26

 

 

 

2

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Receivables

 

 

(1,338

)

 

 

6,662

 

Inventories

 

 

14,670

 

 

 

11,102

 

Other assets

 

 

2,945

 

 

 

3,290

 

Accounts payable

 

 

599

 

 

 

(6,698

)

Accrued payroll and related benefits

 

 

(373

)

 

 

(273

)

Deferred revenue

 

 

1,891

 

 

 

193

 

Income taxes

 

 

(2,032

)

 

 

(1,153

)

Other accrued expenses and liabilities

 

 

(586

)

 

 

(827

)

Net cash provided by operating activities

 

 

80,953

 

 

 

55,924

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Purchases of short term investments

 

 

(30,196

)

 

 

(14,067

)

Proceeds from sales of short term investments

 

 

12,080

 

 

 

4,047

 

Capital additions

 

 

(9,088

)

 

 

(10,444

)

Net cash used in investing activities

 

 

(27,204

)

 

 

(20,464

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Exercise of stock options

 

 

4,144

 

 

 

1,839

 

Employee tax withholdings related to the vesting of equity awards

 

 

(1,596

)

 

 

(2,652

)

Excess tax benefits from share-based compensation

 

 

0

 

 

 

1,766

 

Repurchase and retirement of common stock

 

 

(2,285

)

 

 

0

 

Payment of dividends

 

 

(15,987

)

 

 

(15,587

)

Net cash used in financing activities

 

 

(15,724

)

 

 

(14,634

)

NET INCREASE IN CASH AND CASH EQUIVALENTS

 

 

38,025

 

 

 

20,826

 

CASH AND CASH EQUIVALENTS, beginning of period

 

 

9,623

 

 

 

6,191

 

CASH AND CASH EQUIVALENTS, end of period

 

$

47,648

 

 

$

27,017

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

7


NUTRISYSTEM, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited, in thousands, except per share amounts)

 

1.

BACKGROUND

Nature of the Business

Nutrisystem, Inc. (the “Company” or “Nutrisystem”) is a provider of weight management products and services, including nutritionally balanced weight loss programs sold primarily online and over the telephone, multi-day kits and single items available at select retail locations and digital tools to support weight loss. The weight loss programs are designed for women and men. Additionally, the Nutrisystem® D® program is designed specifically to help people with Type 2 diabetes or at risk for Type 2 diabetes who want to lose weight and manage their diabetes. The Nutrisystem® programs are based on over 40 years of nutrition research. The Company’s pre-packaged foods are sold directly to weight loss program participants primarily through the Internet and telephone (including the redemption of prepaid gift cards), referred to as the direct channel, through QVC, a television shopping network, and select retailers.

2.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Presentation of Financial Statements

The Company’s consolidated financial statements include 100% of the assets and liabilities of Nutrisystem, Inc. and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.

Interim Financial Statements

The Company’s consolidated financial statements as of and for the three and nine months ended September 30, 2017 and 2016 are unaudited and, in the opinion of management, include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the Company’s financial position and results of operations for these interim periods. Accordingly, readers of these consolidated financial statements should refer to the Company’s audited consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), and the related notes thereto, as of and for the year ended December 31, 2016, which are included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “2016 Annual Report”) as certain footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted from this report pursuant to the rules of the Securities and Exchange Commission (the “SEC”).  The results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for the year ending December 31, 2017.

Cash, Cash Equivalents and Short Term Investments

Cash equivalents include only securities having a maturity of three months or less at the time of purchase. At September 30, 2017 and December 31, 2016, demand accounts and money market funds comprised all of the Company’s cash and cash equivalents.  

Short term investments consist of investments in government and agency securities and corporate debt securities with original maturities between three months and three years. The Company classifies these investments as available-for-sale securities. These investments are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive loss, a component of stockholders’ equity, net of related tax effects.

At September 30, 2017, cash, cash equivalents and short term investments consisted of the following:

 

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Cash

 

$

47,432

 

 

$

0

 

 

$

0

 

 

$

47,432

 

Money market funds

 

 

216

 

 

 

0

 

 

 

0

 

 

 

216

 

Government and agency securities

 

 

37,884

 

 

 

114

 

 

 

(158

)

 

 

37,840

 

Corporate debt securities

 

 

4,129

 

 

 

10

 

 

 

(11

)

 

 

4,128

 

 

 

$

89,661

 

 

$

124

 

 

$

(169

)

 

$

89,616

 

 

8


At December 31, 2016, cash, cash equivalents and short term investments consisted of the following:

 

 

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

Cash

 

$

9,166

 

 

$

0

 

 

$

0

 

 

$

9,166

 

Money market funds

 

 

457

 

 

 

0

 

 

 

0

 

 

 

457

 

Government and agency securities

 

 

19,132

 

 

 

51

 

 

 

(96

)

 

 

19,087

 

Corporate debt securities

 

 

4,791

 

 

 

18

 

 

 

(23

)

 

 

4,786

 

 

 

$

33,546

 

 

$

69

 

 

$

(119

)

 

$

33,496

 

 

Fixed Assets

Fixed assets are stated at cost. Depreciation expense is calculated using the straight-line method over the estimated useful lives of the related assets, which are generally two to seven years. Leasehold improvements are amortized on a straight-line basis over the lesser of the estimated useful life of the asset or the related lease term. Expenditures for repairs and maintenance are charged to expense as incurred, while major renewals and improvements are capitalized.

Included in fixed assets is the capitalized cost of internal-use software and website development incurred during the application development stage. Capitalized costs are amortized using the straight-line method over the estimated useful life of the asset, which is generally two to five years. Costs incurred related to planning or maintenance of internal-use software and website development are charged to expense as incurred. The net book value of capitalized software was $17,170 and $17,868 at September 30, 2017 and December 31, 2016, respectively.

Revenue Recognition

Revenue from direct to consumer product sales is recognized when the earnings process is complete, which is upon transfer of title to the product. Recognition of revenue upon shipment meets the revenue recognition criteria in that persuasive evidence of an arrangement exists, delivery has occurred, the selling price is fixed or determinable and collection is reasonably assured. The Company also sells prepaid gift cards to wholesalers. Revenue from these cards is recognized after the card is redeemed online at the Company’s website or via telephone by the customer and the product is shipped to the customer. Revenue from the retail programs is recognized when the product is received at the seller’s location.

Deferred revenue consists primarily of unredeemed prepaid gift cards and unshipped foods. When a customer orders the frozen program, two separate shipments are delivered. One contains Nutrisystem’s ready-to-go food and the other contains the frozen food. Both shipments qualify as separate units of accounting and the fair value is based on estimated selling prices of both units.  

Nutrisystem’s direct to consumer customers may return unopened ready-to-go products within 30 days of purchase in order to receive a refund or credit. Frozen products are non-returnable and non-refundable unless the order is canceled within 14 days of delivery. Estimated returns are accrued at the time the sale is recognized and actual returns are tracked monthly.

The Company reviews the reserves for customer returns at each reporting period and adjusts them to reflect data available at that time. To estimate reserves for returns, the Company considers actual return rates in preceding periods and changes in product offerings or marketing methods that might impact returns going forward. To the extent the estimate of returns changes, the Company will adjust the reserve, which will impact the amount of revenue recognized in the period of the adjustment. The provision for estimated returns for the three and nine months ended September 30, 2017 was $3,949, and $16,129, respectively, and $2,706 and $12,367 for the three and nine months ended September 30, 2016, respectively. The reserve for estimated returns incurred but not received and processed was $1,558 and $740 at September 30, 2017 and December 31, 2016, respectively, and has been included in other accrued expenses and current liabilities in the accompanying consolidated balance sheets.

Revenue from product sales includes amounts billed for shipping and handling and is presented net of estimated returns and billed sales tax. Revenue from the retail programs is also net of any trade allowances, reclamation reserves or broker commissions. Revenue from shipping and handling charges was $1,890 and $5,772 for the three and nine months ended September 30, 2017, respectively, and $687 and $2,290 for the three and nine months ended September 30, 2016, respectively. Shipping-related costs are included in cost of revenue in the accompanying consolidated statements of operations.

9


Dependence on Suppliers

Approximately 11% and 9%, respectively, of inventory purchases for the nine months ended September 30, 2017 were from two suppliers. The Company has a supply arrangement with one of these suppliers that requires the Company to make minimum purchases. For the nine months ended September 30, 2016, these suppliers supplied approximately 11% and 12%, respectively, of inventory purchases.

The Company outsources 100% of its fulfillment operations to a third-party provider. Additionally, more than 98% of its direct to consumer orders are shipped by one third-party provider and more than 98% of its orders for the retail programs are shipped by another third-party provider.

Fair Value of Financial Instruments

A three-tier fair value hierarchy has been established by the Financial Accounting Standards Board (“FASB”) to prioritize the inputs used in measuring fair value. These tiers are as follows:

Level 1—Valuations based on quoted prices for identical assets and liabilities in active markets.

Level 2—Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.

Level 3—Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.

The fair values of the Company’s Level 1 instruments are based on quoted prices in active exchange markets for identical assets. The Company had no Level 2 or 3 instruments at September 30, 2017 and December 31, 2016.

The following table summarizes the Company’s financial assets measured at fair value at September 30, 2017:

 

 

 

Total Fair Value

 

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

 

Money market funds

 

$

216

 

 

$

216

 

Government and agency securities

 

 

37,840

 

 

 

37,840

 

Corporate debt securities

 

 

4,128

 

 

 

4,128

 

Total assets

 

$

42,184

 

 

$

42,184

 

 

The following table summarizes the Company’s financial assets measured at fair value at December 31, 2016:

 

 

 

Total Fair Value

 

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

 

Money market funds

 

$

457

 

 

$

457

 

Government and agency securities

 

 

19,087

 

 

 

19,087

 

Corporate debt securities

 

 

4,786

 

 

 

4,786

 

Total assets

 

$

24,330

 

 

$

24,330

 

 

10


Earnings Per Share

The Company uses the two-class method to calculate earnings per share (“EPS”) as the unvested restricted stock issued under the Company’s equity incentive plans are participating shares with nonforfeitable rights to dividends. Under the two-class method, earnings per common share are computed by dividing the sum of distributed earnings to common stockholders and undistributed earnings allocated to common stockholders by the weighted average number of common shares outstanding for the period. In applying the two-class method, undistributed earnings are allocated to both common shares and participating securities based on the number of weighted average shares outstanding during the period. Undistributed losses are not allocated to unvested restricted stock as the restricted stockholders are not obligated to share in the losses. The following table sets forth the computation of basic and diluted EPS:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Net income

 

$

15,027

 

 

$

7,949

 

 

$

46,946

 

 

$

26,619

 

Net income allocated to unvested restricted stock

 

 

(119

)

 

 

(59

)

 

 

(404

)

 

 

(230

)

Net income allocated to common shares

 

$

14,908

 

 

$

7,890

 

 

$

46,542

 

 

$

26,389

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

29,799

 

 

 

29,320

 

 

 

29,685

 

 

 

29,162

 

Effect of dilutive securities

 

 

500

 

 

 

293

 

 

 

479

 

 

 

303

 

Diluted

 

 

30,299

 

 

 

29,613

 

 

 

30,164

 

 

 

29,465

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income per common share

 

$

0.50

 

 

$

0.27

 

 

$

1.57

 

 

$

0.90

 

Diluted income per common share

 

$

0.49

 

 

$

0.27

 

 

$

1.54

 

 

$

0.90

 

 

In the three and nine months ended September 30, 2017, common stock equivalents representing 142 and 148 shares of common stock, respectively, were excluded from weighted average shares outstanding for diluted income per common share purposes because the effect would be anti-dilutive or the minimum performance requirements for such common stock equivalents have not yet been met. In the three and nine months ended September 30, 2016, common stock equivalents representing 212 and 394 shares of common stock, respectively, were excluded from weighted average shares outstanding for diluted income per common share purposes because the effect would be anti-dilutive or the minimum performance requirements had not yet been met.

Cash Flow Information

The Company made payments for income taxes of $22,705 and $11,900 in the nine months ended September 30, 2017 and 2016. Interest payments in the nine months ended September 30, 2017 and 2016 were $156 and $126, respectively. For the nine months ended September 30, 2017 and 2016, the Company had non-cash capital additions of $727 and $897, respectively, of unpaid invoices in accounts payable and other accrued expenses and current liabilities.  

Recently Issued Accounting Pronouncements

In May 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers,” (“ASU 2014-09”). ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects what it expects in exchange for the goods or services. It also requires more detailed disclosures to enable users of financial statements to understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. This guidance is effective for annual periods beginning on or after December 15, 2017, including interim reporting periods within that reporting period and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently anticipating adopting this standard using the modified retrospective method. Based on its ongoing evaluation of ASU 2014-09, the Company currently does not expect it to have a material impact on the amount or timing of revenue recognition for transactions with customers in the direct or retail channels. The Company continues to evaluate the impact of the new accounting on its gift cards. The Company anticipates recognizing the estimated breakage of gift cards over the pattern of redemption of the gift cards. Currently, the Company recognizes gift card breakage when the likelihood of redemption becomes remote. The Company will also present the revenue and commissions associated with gift cards sold by wholesalers on a gross basis. Currently, the Company presents this revenue on a net basis. The Company expects that these changes in accounting for gift cards will have an impact on the timing of revenue recognition and the gross amount of revenue and expenses presented in the consolidated statements of operations. Additionally, the Company will

11


recognize contract assets for the carrying amount of any product expected to be returned and for any costs to obtain a contract if the contract is more than one year. Product expected to be returned is currently presented as a reduction of the related reserve for returns. The Company is continuing to evaluate the effect that the adoption of this new accounting standard will have on its consolidated financial statements, internal controls and footnote disclosures.

In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory.” An entity using an inventory method other than last-in, first-out or the retail inventory method should measure inventory at the lower of cost and net realizable value. The new guidance clarifies that net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company adopted this new accounting standard in the first quarter of 2017 and it did not have a material impact on the Company’s consolidated financial statements and footnote disclosures.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes,” which eliminates the previous requirement to present deferred tax assets and liabilities as current and noncurrent amounts in a classified statement of financial position. Instead, entities are required to classify all deferred tax assets and liabilities as noncurrent in a statement of financial position. The Company adopted this new accounting standard in the first quarter of 2017, which resulted in a reclassification of $1,642 at December 31, 2016 from current deferred income taxes to non-current deferred income taxes in the accompanying consolidated balance sheet.

In February 2016, the FASB issued ASU No. 2016-02, “Leases,” which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. This standard is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and footnote disclosures.

In March 2016, the FASB issued ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting,” which simplifies several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company adopted this standard in the first quarter of 2017 and recognized an excess tax benefit from share-based compensation of $1,007 and $3,714, respectively, for the three and nine months ended September 30, 2017 within income tax expense on the accompanying consolidated statements of operations as opposed to being recognized in additional paid-in capital under previous accounting guidance. In addition, the excess tax benefits from share-based compensation are now classified as operating cash flows on the consolidated statements of cash flows instead of being separately stated in the financing activities for the nine months ended September 30, 2017. The prior period has not been restated. The Company has elected to continue to estimate expected forfeitures.

In August 2016, the FASB issued ASU No. 2016-15, “Classification of Certain Cash Receipts and Cash Payments,” which clarifies and provides guidance on eight cash flow classification issues and is intended to reduce existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This standard is effective for annual periods beginning after December 15, 2017, and interim periods within those fiscal years.  Early adoption is permitted, including adoption in an interim period. The adoption of this new accounting standard is not expected to have a material impact on the Company’s consolidated financial statements and footnote disclosures.

In May 2017, the FASB issued ASU No. 2017-09, “Scope of Modification Accounting,” which provides guidance about which changes to the terms or conditions of share-based payment awards require an entity to apply modification accounting. This standard is effective for annual periods beginning after December 15, 2017, and interim periods within those fiscal years.  Early adoption is permitted, including adoption in an interim period. The adoption of this new accounting standard is not expected to have a material impact on the Company’s consolidated financial statements and footnote disclosures.

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and operating expenses during the reporting period. Actual results could differ from these estimates.

Reclassifications

Certain reclassifications have been made to prior year amounts to conform to the current year presentation.

12


3.

INTANGIBLE ASSETS

On December 17, 2015, the Company acquired the South Beach Diet (“SBD”) brand for a cash payment of $15,000. The acquisition was financed with existing cash.

The Company developed the South Beach Diet® meal programs, products, and services in 2016 and launched a structured meal delivery weight-loss program as a distinct brand in 2017. The acquisition provides consumers with additional choices and enables the Company the ability to capture a greater share of the commercial weight loss market as it further leverages its expertise in product development, marketing, ecommerce, supply chain logistics and retail.

The allocation of the purchase price was to the SBD trade name and is being amortized on a straight-line basis over a period of 15 years. The fair value measurement method used to measure the assets acquired utilized a number of significant unobservable inputs or Level 3 assumptions. These assumptions included, among others, projections of the acquired businesses future operating results, the implied fair value of assets using an income approach by preparing a discounted cash flow analysis and other subjective assumptions.

The following table summarizes the Company’s identifiable intangible assets:

 

 

 

September 30, 2017

 

 

December 31, 2016

 

 

 

Gross

 

 

 

 

 

 

Net

 

 

Gross

 

 

 

 

 

 

Net

 

 

 

Carrying

 

 

Accumulated

 

 

Carrying

 

 

Carrying

 

 

Accumulated

 

 

Carrying

 

 

 

Amount

 

 

Amortization

 

 

Amount

 

 

Amount

 

 

Amortization

 

 

Amount

 

Trade name

 

$

15,000

 

 

$

(1,750

)

 

$

13,250

 

 

$

15,000

 

 

$

(1,000

)

 

$

14,000

 

 

Amortization expense for intangible assets was $750 in both the nine months ended September 30, 2017 and 2016. Estimated amortization expense for the next five years is expected to be as follows:

 

Remaining 2017

 

$

250

 

2018

 

 

1,000

 

2019

 

 

1,000

 

2020

 

 

1,000

 

2021

 

 

1,000

 

 

Additionally, the Company has $84 of domain names acquired in previous years with indefinite lives that are not being amortized.

 

 

4.

CREDIT FACILITY

On November 6, 2015, the Company entered into an Amended and Restated Credit Agreement that provides for a $50,000 unsecured revolving credit facility (the “Credit Facility”) with a lender. The Credit Facility can be drawn upon through November 6, 2020, at which time all amounts must be repaid. There were no borrowings outstanding at September 30, 2017 or December 31, 2016.

The Credit Facility provides for interest at either a base rate or a LIBOR rate, in each case plus an applicable margin. The base rate will be the highest of (i) the Administrative Agent’s prime rate, (ii) 0.50% above the Federal Funds Rate and (iii) the LIBOR rate for deposits in dollars for a one-month interest period as determined three business days prior to such date, plus 1.50%. The LIBOR rate is equal to the London Inter-Bank Offered Rate for the relevant term. The applicable margin is subject to adjustment based on the Company’s consolidated fixed charge coverage ratio and ranges from 0.00-0.50% per year for base rate loans and from 1.25-1.75% per year for LIBOR rate loans. The Company also pays an unused line fee. The unused line fee is 0.25% of the total available credit. During both the three and nine months ended September 30, 2017, the Company incurred no interest expense and $32 and $95, respectively, in an unused line fee under the Credit Facility. In the comparable periods of 2016, the Company incurred no interest expense and $32 and $95 in unused line fees, respectively.  Interest payments and unused line fees are classified within interest (income) expense, net in the accompanying consolidated statements of operations.

The Credit Facility contains financial and other covenants including a minimum consolidated fixed charge coverage ratio (applicable if there are outstanding borrowings), and limitations on, among other things, liens, indebtedness, certain acquisitions, consolidations and sales of assets. As of September 30, 2017, the Company was in compliance with all covenants contained in the Credit Facility.

At September 30, 2017, the Company had $15 of unamortized debt issuance costs associated with the Credit Facility that are being amortized over its remaining term.

 

 

13


5.

CAPITAL STOCK

Common Stock

The Company issued 261 and 181 shares of common stock upon the exercise of stock options in the nine months ended September 30, 2017 and 2016, respectively, and received proceeds of $4,144 and $1,839, respectively. During the nine months ended September 30, 2017 and 2016, employees surrendered to the Company 34 and 128 shares of common stock, respectively, valued at $1,596 and $2,652, respectively, in satisfaction of tax withholding obligations associated with the vesting of equity awards. These shares are included in treasury stock. Additionally, during the nine months ended September 30, 2017, employees surrendered to the Company 22 shares of common stock valued at $785, also in satisfaction of tax withholding obligations, which were retired. In the nine months ended September 30, 2017 and 2016, the Company issued 14 and 27 shares of common stock, respectively, as compensation to board members. Costs recognized for these stock grants issued were $700 for both the nine months ended September 30, 2017 and 2016, respectively. During each of the quarters in the nine months ended September 30, 2017 and 2016, the Company paid a dividend of $0.175 per share to all stockholders of record. Subsequent to September 30, 2017, the Company’s Board of Directors declared a quarterly dividend of $0.175 per share payable on November 16, 2017 to stockholders of record as of November 6, 2017.

On May 3, 2016, the Company announced that its Board of Directors had authorized the repurchase of up to $50,000 of its outstanding shares of common stock in open-market transactions or otherwise over the next 18-month period. During the nine months ended September 30, 2017, the Company purchased and subsequently retired 29 shares of common stock under this program for an aggregate cost of $1,500. On October 25, 2017, the Company announced that its Board of Directors had authorized a new share repurchase program to replace its existing share repurchase program that expires on November 3, 2017. The Company may repurchase up to $50,000 of its outstanding shares of common stock over a 24-month period commencing November 4, 2017. The timing, number and amount of any shares repurchased will be determined by the Company at its discretion and will be based on a number of factors including its evaluation of general market and economic conditions, the trading price of the common stock, regulatory requirements and compliance with the terms of the Company’s outstanding indebtedness. The stock repurchase program may be suspended or discontinued at any time without prior notice.  

Preferred Stock

The Company has authorized 5,000 shares of preferred stock issuable in series upon resolution of the Board of Directors. Unless otherwise required by law, the Board of Directors can, without stockholder approval, issue preferred stock in the future with voting and conversion rights that could adversely affect the voting power of the common stock. The issuance of preferred stock may have the effect of delaying, averting or preventing a change in control of the Company.

6.

SHARE-BASED COMPENSATION EXPENSE

The following table summarizes the Company’s stock option activity during the nine months ended September 30, 2017:  

 

 

 

Number of Shares

 

 

Weighted-Average

Exercise Price Per

Share

 

 

Weighted-Average

Remaining

Contractual Life

(years)

 

 

Aggregate Intrinsic

Value

 

Outstanding, January 1, 2017

 

 

577

 

 

$

16.04

 

 

 

 

 

 

 

 

 

Granted

 

 

0

 

 

 

0.00

 

 

 

 

 

 

 

 

 

Exercised

 

 

(261

)

 

 

15.90

 

 

 

 

 

 

 

 

 

Forfeited/expired

 

 

0

 

 

 

0.00

 

 

 

 

 

 

 

 

 

Outstanding, September 30, 2017

 

 

316

 

 

$

16.15

 

 

 

4.00

 

 

$

12,570

 

Exercisable, September 30, 2017

 

 

110

 

 

$

9.91

 

 

 

2.69

 

 

$

5,043

 

Vested and expected to vest at September 30, 2017

 

 

313

 

 

$

16.12

 

 

 

4.00

 

 

$

12,468

 

 

The Company recorded compensation expense of $204 and $679 in the accompanying consolidated statements of operations during the three and nine months ended September 30, 2017, respectively, for stock option awards. During the three and nine months ended September 30, 2016, the Company recorded compensation expense of $264 and $819, respectively. The total intrinsic value of stock options exercised during the three and nine months ended September 30, 2017 was $2,847 and $8,269, respectively, and $1,610 and $3,010, respectively, for the comparable periods of 2016.

14


The Company has issued restricted stock to employees generally with vesting terms ranging from two to four years. The fair value is equal to the market price of the Company’s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period. The following table summarizes the restricted stock activity for the nine months ended September 30, 2017:

 

 

 

Number of Shares

 

 

Weighted-Average

Grant-Date Fair

Value

 

 

Aggregate Intrinsic

Value

 

Nonvested, January 1, 2017

 

 

216

 

 

$

21.51

 

 

 

 

 

Granted

 

 

140

 

 

 

35.11

 

 

 

 

 

Vested

 

 

(117

)

 

 

14.78

 

 

 

 

 

Forfeited

 

 

(2

)

 

 

29.53

 

 

 

 

 

Nonvested, September 30, 2017

 

 

237

 

 

$

32.87

 

 

$

13,220

 

 

Additionally, the Company grants performance-based restricted stock units. The performance-based units have performance conditions and service-based vesting conditions. Each vesting tranche is treated as an individual award and the compensation expense is recognized on a straight-line basis over the requisite service period for each tranche. The requisite service period is a combination of the performance period and the subsequent vesting period based on continued service. The level of achievement of such goals may cause the actual amount of units that ultimately vest to range from 0% to 200% of the original units granted. The Company recognizes expense ratably over the vesting period for performance-based restricted stock units when it is probable that the performance criteria specified will be achieved. The fair value is equal to the market price of the Company’s common stock on the date of grant.  

The following table summarizes the restricted stock unit activity for the nine months ended September 30, 2017:  

 

 

 

Number of

Restricted Stock

Units

 

 

Weighted-Average

Grant-Date Fair

Value

 

 

Aggregate Intrinsic

Value

 

Nonvested, January 1, 2017

 

 

281

 

 

$

23.18

 

 

 

 

 

Granted

 

 

73

 

 

 

35.75

 

 

 

 

 

Vested

 

 

(26

)

 

 

21.64

 

 

 

 

 

Forfeited

 

 

(1

)

 

 

20.52

 

 

 

 

 

Nonvested, September 30, 2017

 

 

327

 

 

$

26.11

 

 

$

18,304

 

 

The Company recorded compensation expense of $2,421 and $6,520 in the accompanying consolidated statements of operations for the three and nine months ended September 30, 2017, respectively, and $1,204 and $3,615, respectively, for the comparable periods of 2016 in connection with the issuance of the restricted stock and restricted stock units. As of September 30, 2017, the Company expects 231 shares of restricted stock and 322 restricted stock units to vest.

As of September 30, 2017, there was $9,677 of total unrecognized compensation expense related to unvested share-based compensation arrangements, which is expected to be recognized over a weighted-average period of 1.0 year. The total unrecognized compensation expense will be fully charged to expense through the first quarter of 2020.

 

 

7.

COMMITMENTS AND CONTINGENCIES

Litigation

The Company is involved in various claims and routine litigation matters that arise in the ordinary course of business. In the opinion of management, after consultation with legal counsel, the outcomes of such matters are not anticipated to have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows in future years and management believes the range of reasonably possible losses from current matters is immaterial.

Contractual Commitments

The Company has entered into agreements with various food suppliers. These agreements may provide for annual pricing, annual purchase obligations, exclusivity in the production of certain products, as well as rebates if certain volume thresholds are exceeded, with terms of five years or less. The Company anticipates it will meet all annual purchase obligations in 2017.

8.

INCOME TAXES

The Company recorded income taxes at an estimated effective income tax rate applied to income before income tax expense of 35.1% in both the three and nine months ended September 30, 2017, respectively, which was reduced to 29.8% and 29.5%, respectively, after

15


recording discrete items, due primarily to the adoption of ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting” as of January 1, 2017. The Company recognized an excess tax benefit from share-based compensation of $1,007 and $3,714 in the three and nine months ended September 30, 2017, respectively, within income tax expense in the accompanying consolidated statements of operations rather than as additional paid-in capital in the accompanying consolidated balance sheet under previous accounting guidance. The effective income tax rate applied to income before income tax expense was 35.6% and 34.7% in the three and nine months ended September 30, 2016, respectively. The Company offsets taxable income for state tax purposes with net operating loss carryforwards. At December 31, 2016, the Company had net operating loss carryforwards of approximately $28,038 for state tax purposes. For state tax purposes, there is a limitation on the amount of net operating loss carryforwards that can be utilized in a given year to offset state taxable income and management believes that some of the net operating loss carryforwards will be subject to this annual limit in 2017. State net operating loss carryforwards will begin to expire in 2025. The total amount of gross unrecognized tax benefits as of September 30, 2017 and December 31, 2016 was $190 and $168, respectively. The total amount of unrecognized tax benefits that, if recognized, would affect the effective income tax rate is approximately $124 and $109 as of September 30, 2017 and December 31, 2016, respectively.

16


Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

From time to time, information provided by us, including but not limited to statements in this Quarterly Report, or other statements made by or on our behalf, may contain “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “estimate,” “will be,” “will,” “would,” “expect,” “anticipate,” “plan,” “project,” “intend,” “could,” “should,” or other similar words or expressions often identify forward-looking statements.

Such statements are based on current expectations only, and are subject to certain risks, uncertainties, and assumptions, many of which are beyond our control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results, performance, or achievements may vary materially from those anticipated, estimated, or projected. Among the factors that could cause actual results to materially differ include:

 

competition from other weight management industry participants or the development of more effective or more favorably perceived weight management methods;

 

our ability to continue to develop innovative new programs and enhance our existing programs, or the failure of our programs to continue to appeal to the market;

 

the effectiveness of our marketing and advertising programs;

 

loss, or disruption in the business, of any of our food suppliers;

 

loss, or disruption in the business, of our fulfillment provider;

 

disruptions in the shipping of our food products;

 

claims that our personnel are unqualified to provide proper weight loss advice and other health or advertising related claims by consumers;

 

failure to attract or negative publicity with respect to any of our spokespersons or negative publicity with respect to the weight loss industry;

 

our ability to successfully make acquisitions or enter into joint ventures, including our ability to successfully integrate, operate or realize the projected benefits of such businesses;

 

general business and economic conditions;

 

the seasonal nature of our business;

 

loss of any of our third-party retailer agreements and any obligations associated with such loss;

 

our ability to enforce our intellectual property rights, as well as the impact of our involvement in any claims related to intellectual property rights;

 

uncertainties regarding the satisfactory operation of our information technology or systems;

 

risks associated with unauthorized penetration of our information security;

 

the impact of existing and future laws and regulations;

 

exposure to product liability claims if the use of our products results in illness or injury;

 

the impact of our debt covenants;

 

our inability to recruit and retain key executive officers;

 

potential litigation from our competitors;

 

provisions in our certificate of incorporation may deter or delay an acquisition or prevent a change in control; and

 

other risks and uncertainties, including those detailed herein and from time to time in our periodic reports filed with the SEC.

We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Our 2016 Annual Report listed various important factors that could cause actual results to differ materially from projected and historic results. We note these factors for investors as permitted by the Private Securities Litigation Reform Act of 1995. Readers can find

17


them in Part I, Item 1A, of that filing under the heading “Risk Factors.” We incorporate that section of the 2016 Annual Report in this filing and investors should refer to it. Reference is also made to Part II, Item 1A, “Risk Factors,” of this Quarterly Report on Form 10-Q. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.

The following discussion should be read in conjunction with the financial information included elsewhere in this Quarterly Report on Form 10-Q.  

Overview

Nutrisystem, Inc. (“Nutrisystem,” the “Company,” “we,” “us,” or “our”) is a provider of weight management products and services, including nutritionally balanced weight loss programs sold primarily online and over the telephone, multi-day kits and single items available at select retail locations and digital tools to support weight loss. The weight loss programs are designed for women and men. Additionally, our Nutrisystem® D® program is designed specifically to help people with Type 2 diabetes or at risk for Type 2 diabetes, who want to lose weight and manage their diabetes. Our programs are based on over 40 years of nutrition research. Our food is created to be nutritious, delicious and portioned for weight loss and management. Our pre-packaged foods are sold directly to weight loss program participants primarily through the Internet and telephone (including the redemption of prepaid gift cards), referred to as the direct channel, through QVC, a television shopping network, and select retailers.  

Revenue consists primarily of food sales. In the nine months ended September 30, 2017, the direct channel accounted for 92% of revenue compared to 5% for retail and 3% for QVC. In the nine months ended September 30, 2016, the direct channel accounted for 91% of revenue compared to 6% for retail and 3% for QVC. We incur significant marketing expenditures to support our brands as we continue to advertise across various media channels. New media channels are tested on a continual basis and we consider our media mix to be diverse. We market our weight loss systems through television, print, direct mail, Internet, public relations and social media. We review and analyze a number of key operating and financial metrics to manage our business, including the number of new customers, revenue per customer, reactivation revenue, total revenue, marketing per new customer and operating margins.

Our ecommerce, direct-to-consumer business model provides flexibility which allows us to manage marketing spend according to customer demand. We believe this flexibility is especially valuable as it allows us to react to changing market conditions relatively quickly. Additionally, we are continually looking to make investments to improve lifetime customer economics, length of stay and overall customer satisfaction. We are able to test new commercials, offers and website configurations to allow us to be more responsive to customer needs and attempt to drive conversion.

We offer customizable programs. Customers are given a meal plan, access to trackers and tools via NuMi by Nutrisystem (an easy-to-use, interactive and personalized weight loss tracking tool), educational digital content and exercise suggestions. Customers are also encouraged to check in periodically with a counselor as their needs change in response to weight loss.

In December 2016, we announced our multi-brand approach with two distinct programs, the clinically-tested Nutrisystem® Lean13 and the all new South Beach Diet®. The Lean13 is designed to deliver weight loss of up to 13 pounds and seven inches in the first month. South Beach Diet® launched in January 2017 as a structured meal delivery weight-loss program. The plan features fully prepared, globally inspired meals that are flash-frozen to maintain the quality of taste and nutrition, and delivered right to the customer’s doorstep. The South Beach Diet was created by Dr. Arthur Agatston, a cardiologist from southern Florida. In 2003, he published “The South Beach Diet,” which became a bestseller with more than 23 million copies in print and multiple titles appearing on the New York Times bestseller list.

Additionally, our multi-day weight loss kits are available at select retailers. The retail channel provides us with great brand exposure, offering consumers who may not be aware of our programs an opportunity to sample Nutrisystem at a more attractive price point. Also, we continue to offer our Nutrisystem® programs through the use of prepaid gift cards. We are actively developing our retail product pipeline and have multiple kits and single items available for purchase.  

We believe these new product and program innovations are resonating well with our customers. We provide an increasingly diverse array of weight loss solutions for our customers through an expanding portfolio of products. Our customers now have greater flexibility in choosing between ready-to-go and frozen options, with no restrictions. We believe this translates into higher customer satisfaction and more profit. We have expanded our television and digital reach to both introduce ourselves to new consumers and build brand awareness and to start testing expansion opportunities. Upsell and a la carte sales, including shakes and additional flexible options have continued to grow as more people are adding them to their orders. Revenue for the nine months ended September 30, 2017 increased 30% from the comparable period of 2016 to $565.7 million. Our revenue growth was attributable primarily to the direct channel due to revenue from new customers in their initial diet cycle, the reactivation of former customers and increased sales of our premium products. Reactivation revenue increased due to higher volumes building off of recent increases in new customer

18


counts and a higher reactivation rate. Retail and QVC revenue also increased during the nine months ended September 30, 2017 as compared to the prior period.

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with GAAP. Our significant accounting policies are described in Note 2 of the consolidated financial statements included in Item 8 of our 2016 Annual Report.

The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Management develops, and changes periodically, these estimates and assumptions based on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. The accounting estimates we consider critical include reserves for returns, excess and obsolete inventory and income taxes. These critical accounting estimates are discussed with our audit committee quarterly.

During the nine months ended September 30, 2017, we did not make any material change to our critical accounting policies.

Results of Operations

Revenue and expenses consist of the following components:

Revenue.  Revenue consists primarily of food sales. Food sales include sales of food, supplements, shipping and handling charges billed to customers and sales credits and adjustments, including product returns. Revenue from the retail programs is also net of any trade allowances, reclamation reserves or broker commissions. No revenue is recorded for food products provided at no charge as part of promotions.  

Cost of Revenue.  Cost of revenue consists primarily of the cost of the products sold, including compensation related to fulfillment, the costs of outside fulfillment, incoming and outgoing shipping costs, charge card fees and packing material. Cost of products sold includes products provided at no charge as part of promotions and the non-food materials provided with customer orders.

Marketing Expense.  Marketing expense includes media, advertising production, marketing and promotional expenses and payroll-related expenses, including share-based payment arrangements, for personnel engaged in these activities. Internet advertising expense is recorded based on either the rate of delivery of a guaranteed number of impressions over the advertising contract term or on a cost per customer acquired, depending upon the terms. Direct-mail advertising costs are capitalized if the primary purpose was to elicit sales to customers who could be shown to have responded specifically to the advertisements and results in probable future economic benefits. The capitalized costs are amortized to expense over the period during which the future benefits are expected to be received. All other advertising costs are charged to expense as incurred or the first time the advertising takes place.

General and Administrative Expense.  General and administrative expense consists of compensation for administrative, information technology, call center and sales personnel, share-based payment arrangements for related employees, facility expenses, website development costs, professional service fees and other general corporate expenses.

Interest (Income) Expense, Net.  Interest (income) expense, net consists of interest income earned on cash balances and short term investments net of interest expense and unused line fees on our revolving credit facility.

Income Tax Expense.  We are subject to corporate level income taxes and record income taxes based on an effective income tax rate for the year.

Overview of the Direct Channel

In the nine months ended September 30, 2017 and 2016 the direct channel represented 92% and 91%, respectively, of our revenue. Revenue through the direct channel was $147.0 million and $522.7 million in the three and nine months ended September 30, 2017 compared to $114.9 million and $398.9 million in the same period of 2016. Revenue is generated primarily through customer starts, reactivation of former customers and the customer ordering behavior, including length of time on our program and the diet program selection. The revenue increase in 2017 was attributable primarily to revenue from new customers in their initial diet cycle, reactivation revenue and increased sales of our premium product. Critical to increasing customer starts is our ability to deploy marketing dollars while maintaining marketing effectiveness. Factors influencing our marketing effectiveness include the quality of the advertisements, promotional activity by our competitors, as well as the price and availability of appropriate media.

19


Three Months Ended September 30, 2017 Compared to Three Months Ended September 30, 2016

 

 

 

Three Months Ended September 30,

 

 

 

2017

 

 

2016

 

 

$ Change

 

 

% Change

 

 

 

(in thousands)

 

REVENUE

 

$

158,149

 

 

$

124,571

 

 

$

33,578

 

 

 

27

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COSTS AND EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

72,357

 

 

 

57,694

 

 

 

14,663

 

 

 

25

%

Marketing

 

 

42,067

 

 

 

33,499

 

 

 

8,568

 

 

 

26

%

General and administrative

 

 

18,626

 

 

 

16,707

 

 

 

1,919

 

 

 

11

%

Depreciation and amortization

 

 

3,755

 

 

 

4,332

 

 

 

(577

)

 

 

(13

)%

Total costs and expenses

 

 

136,805

 

 

 

112,232

 

 

 

24,573

 

 

 

22

%

Operating income

 

 

21,344

 

 

 

12,339

 

 

 

9,005

 

 

 

73

%

INTEREST INCOME, net

 

 

(48

)

 

 

(11

)

 

 

(37

)

 

 

336

%

Income before income tax expense

 

 

21,392

 

 

 

12,350

 

 

 

9,042

 

 

 

73

%

INCOME TAX EXPENSE

 

 

6,365

 

 

 

4,401

 

 

 

1,964

 

 

 

45

%

Net income

 

$

15,027

 

 

$

7,949

 

 

$

7,078

 

 

 

89

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

% of revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

 

54.2

%

 

 

53.7

%

 

 

 

 

 

 

 

 

Marketing

 

 

26.6

%

 

 

26.9

%

 

 

 

 

 

 

 

 

General and administrative

 

 

11.8

%

 

 

13.4

%

 

 

 

 

 

 

 

 

Operating income

 

 

13.5

%

 

 

9.9

%

 

 

 

 

 

 

 

 

 

Revenue.  Revenue increased to $158.1 million in the third quarter of 2017 from $124.6 million for the third quarter of 2016. The increase in revenue is attributable primarily to revenue from new customers in their initial diet cycle ($22.3 million) and reactivation revenue ($9.9 million). In the third quarter of 2017, the direct channel accounted for 93% of revenue compared to 5% for retail and 2% for QVC. In the third quarter of 2016, the direct channel accounted for 92% of revenue compared to 6% for retail and 2% for QVC.

Costs and Expenses.  Cost of revenue increased to $72.4 million in the third quarter of 2017 from $57.7 million in the third quarter of 2016. Gross margin as a percent of revenue increased to 54.2% in the third quarter of 2017 from 53.7% for the third quarter of 2016. The increase in gross margin was attributable primarily to lower food costs from the direct channel and increases in average selling prices which offset increased packaging and freight costs due to increased sales of our frozen products.

Marketing expense increased to $42.1 million in the third quarter of 2017 from $33.5 million in the third quarter of 2016. Marketing expense as a percent of revenue decreased to 26.6% in the third quarter of 2017 from 26.9% for the third quarter of 2016. Substantially all marketing spending promoted the direct channel. The increase in marketing expense was attributable primarily to increased spending for advertising media ($7.8 million), higher marketing compensation and benefits ($513,000) and an increase in television production ($286,000).  These increases were partially offset by a decrease in public relations ($146,000). In total, media spending was $36.5 million in the third quarter of 2017 and $28.7 million in the third quarter of 2016.

General and administrative expense increased to $18.6 million in the third quarter of 2017 compared to $16.7 million in the third quarter of 2016. General and administrative expense as a percent of revenue decreased to 11.8% in the third quarter of 2017 from 13.4% for the third quarter of 2016. The increase in spending was attributable primarily to higher compensation, benefits and commissions ($1.3 million), higher non-cash expense for share-based payment arrangements ($777,000) and increased professional, outside and computer services ($423,000). These increases were partially offset by decreased spending in new packaging design ($485,000).

Depreciation and amortization expense decreased to $3.8 million in the third quarter of 2017 compared to $4.3 million in the third quarter of 2016 as the third quarter of 2016 included a charge of $1.3 million to write-down certain software licenses.

Interest Income, Net. Interest income, net was $48,000 in the third quarter of 2017 compared to $11,000 in the third quarter of 2016 due to higher interest income offset by a lower amount of amortization of capitalized debt issuance costs associated with our credit facility.  

Income Tax Expense. We recorded income taxes at an estimated effective income tax rate applied to income before income tax expense of 35.1% for the third quarter of 2017, which was reduced to 29.8% after recording discrete items, due primarily to the

20


adoption of ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting,” as of January 1, 2017. Income tax expense in the third quarter of 2017 was $6.4 million. We recognized an excess tax benefit from share-based compensation of $1.0 million within income tax expense rather than as additional paid-in capital under previous accounting guidance which offset an increase in the effective tax rate for state income taxes. In the third quarter of 2016, we recorded an income tax expense of $4.4 million, which reflects an effective income tax rate of 35.6%.

Nine Months Ended September 30, 2017 Compared to Nine Months Ended September 30, 2016

 

 

 

Nine Months Ended September 30,

 

 

 

2017

 

 

2016

 

 

$ Change

 

 

% Change

 

 

 

(in thousands)

 

REVENUE

 

$

565,720

 

 

$

436,504

 

 

$

129,216

 

 

 

30

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COSTS AND EXPENSES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

259,684

 

 

 

205,394

 

 

 

54,290

 

 

 

26

%

Marketing

 

 

168,585

 

 

 

128,441

 

 

 

40,144

 

 

 

31

%

General and administrative

 

 

59,620

 

 

 

51,744

 

 

 

7,876

 

 

 

15

%

Depreciation and amortization

 

 

11,321

 

 

 

10,160

 

 

 

1,161

 

 

 

11

%

Total costs and expenses

 

 

499,210

 

 

 

395,739

 

 

 

103,471

 

 

 

26

%

Operating income

 

 

66,510

 

 

 

40,765

 

 

 

25,745

 

 

 

63

%

INTEREST (INCOME) EXPENSE, net

 

 

(74

)

 

 

23

 

 

 

(97

)

 

 

(422

)%

Income before income tax expense

 

 

66,584

 

 

 

40,742

 

 

 

25,842

 

 

 

63

%

INCOME TAX EXPENSE

 

 

19,638

 

 

 

14,123

 

 

 

5,515

 

 

 

39

%

Net income

 

$

46,946

 

 

$

26,619

 

 

$

20,327

 

 

 

76

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

% of revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

 

54.1

%

 

 

52.9

%

 

 

 

 

 

 

 

 

Marketing

 

 

29.8

%

 

 

29.4

%

 

 

 

 

 

 

 

 

General and administrative

 

 

10.5

%

 

 

11.9

%

 

 

 

 

 

 

 

 

Operating income

 

 

11.8

%

 

 

9.3

%

 

 

 

 

 

 

 

 

 

Revenue.  Revenue increased to $565.7 million in the nine months ended September 30, 2017 from $436.5 million in the comparable period of 2016. The increase in revenue is attributable primarily to revenue from new customers in their initial diet cycle ($96.0 million), reactivation revenue ($28.3 million) and increased retail revenue ($4.3 million). In the nine months ended September 30, 2017, the direct channel accounted for 92% of revenue compared to 5% for retail and 3% for QVC. In the nine months ended September 30, 2016, the direct channel accounted for 91% of revenue compared to 6% for retail and 3% for QVC.

Costs and Expenses.  Cost of revenue increased to $259.7 million in the nine months ended September 30, 2017 from $205.4 million in the comparable period of 2016. Gross margin as a percent of revenue increased to 54.1% in the nine months ended September 30, 2017 from 52.9% for the comparable period of 2016. The increase in gross margin was attributable primarily to lower food costs from the direct channel, less promotional costs from retail and increases in average selling prices partially offset by increased packaging and freight costs due to the increased sales of our frozen products.

Marketing expense increased to $168.6 million in the nine months ended September 30, 2017 from $128.4 million in the comparable period of 2016. Marketing expense as a percent of revenue increased to 29.8% in the nine months ended September 30, 2017 from 29.4% for the comparable period of 2016. Substantially all marketing spending promoted the direct channel. The increase in marketing expense was attributable primarily to increased spending for advertising media ($41.3 million) and higher marketing compensation and benefits ($1.4 million).  These increases were partially offset by decreased television production ($1.5 million) and public relations ($489,000). In total, media spending was $153.8 million in the nine months ended September 30, 2017 and $112.5 million in the nine months ended September 30, 2016.

General and administrative expense increased to $59.6 million in the nine months ended September 30, 2017 from $51.7 million in the comparable period of 2016. General and administrative expense as a percent of revenue decreased to 10.5% in the nine months ended September 30, 2017 from 11.9% in the comparable period of 2016. The increase in spending was due primarily to higher compensation, benefits and commissions ($5.1 million), higher non-cash expense for share-based payment arrangements ($1.7 million) and higher professional, outside and computer services ($1.3 million). These increases were partially offset by decreased spending in new packaging design ($390,000) and research and development ($378,000).

21


Depreciation and amortization expense increased to $11.3 million in the nine months ended September 30, 2017 compared to $10.2 million in the nine months ended September 30, 2016 due to increased capital expenditures for our website, digital tools and our new warehouses.

Interest (Income) Expense, net.  Interest income, net was $74,000 in the nine months ended September 30, 2017 compared to interest expense, net of $23,000 in the comparable period of 2016 due to higher interest income and a lower amount of amortization of capitalized debt issuance costs associated with our credit facility.

Income Tax Expense.  We recorded income taxes at an estimated effective income tax rate applied to income before income tax expense of 35.1% for the nine months ended September 30, 2017, which was reduced to 29.5% after recording discrete items, due primarily to the adoption of ASU No. 2016-09, “Improvements to Employee Share-Based Payment Accounting,” as of January 1, 2017. Income tax expense in the nine months ended September 30, 2017 was $19.6 million. We recognized an excess tax benefit from share-based compensation of $3.7 million within income tax expense rather than as additional paid-in capital under previous accounting guidance which offset an increase in the effective tax rate for state income taxes. In the nine months ended September 30, 2016, we recorded an income tax expense of $14.1 million, which reflects an effective income tax rate of 34.7%.

Contractual Obligations and Commercial Commitments

As of September 30, 2017, our principal commitments consisted of obligations under agreements with food suppliers, an agreement with our outside fulfillment provider, agreements with our Internet and networking providers, operating leases and employment contracts. Although we have no material commitments for capital expenditures, we anticipate continuing requirements for capital expenditures.

Liquidity, Capital Resources and Other Financial Data

At September 30, 2017, we had working capital of $81.9 million as compared to $41.8 million at December 31, 2016. Cash and cash equivalents at September 30, 2017 were $47.6 million, an increase of $38.0 million from the balance of $9.6 million at December 31, 2016. In addition, we had $42.0 million invested in short term investments at September 30, 2017, as compared to $23.9 million at December 31, 2016, an increase of $18.1 million. Our principal sources of liquidity during this period were cash flows from operations.  

On November 6, 2015, we entered into a $50.0 million unsecured revolving credit facility with a lender. The credit facility provides for interest on borrowings at either a base rate or the London Inter-Bank Offered Rate, in each case plus an applicable margin and is also subject to an unused fee payable quarterly. The credit facility contains financial and other covenants, including a minimum consolidated fixed charge coverage ratio (applicable if there are outstanding borrowings), and limitations on, among other things, liens, indebtedness, certain acquisitions, consolidations and sales of assets. The credit facility can be drawn upon through November 6, 2020, at which time all amounts must be repaid. There were no borrowings outstanding at September 30, 2017 or December 31, 2016.

In the nine months ended September 30, 2017, we generated cash flows of $81.0 million from operating activities, an increase of $25.0 million from the same period of 2016. An increase of $20.3 million in net income and $3.5 million of additional cash flow provided by the net change in operating assets and liabilities were the primary drivers of increased cash flow from operations largely due to the increase in demand for our products.

In the nine months ended September 30, 2017, net cash used in investing activities was $27.2 million, an increase of $6.7 million from the same period of 2016, as we invested additional amounts in short term investments. Capital additions decreased by $1.4 million in the nine months ended September 30, 2017 as compared to the same period of 2016 as the prior year included additions for the launch of South Beach Diet and additional ecommerce projects.

In the nine months ended September 30, 2017, net cash used in financing activities was $15.7 million, an increase of $1.1 million from the same period of 2016, as we increased stock repurchases and paid slightly more dividends offset by additional proceeds from the exercise of stock options. During the nine months ended September 30, 2017, we paid $16.0 million for dividends, $2.3 million to repurchase and retire shares of common stock and $1.6 million to satisfy the tax withholding obligations associated with the vesting of equity awards partially offset by the proceeds received from the exercise of stock options.

On May 3, 2016, we announced our Board of Directors had authorized the repurchase of up to $50.0 million of our outstanding shares of common stock in open-market transactions or otherwise over the next 18-month period. During the nine months ended September 30, 2017, we purchased and subsequently retired 28,675 shares of common stock under this program for an aggregate cost of $1.5 million. On October 25, 2017, we announced that our Board of Directors had authorized a new share repurchase program to replace our existing share repurchase program that expires on November 3, 2017. We may repurchase up to $50.0 million of our outstanding shares of common stock over a 24-month period commencing November 4, 2017. The timing, number and amount of any shares

22


repurchased will be determined by us at our discretion and will be based on a number of factors including our evaluation of general market and economic conditions, the trading price of the common stock, regulatory requirements and compliance with the terms of our outstanding indebtedness. The stock repurchase program may be suspended or discontinued at any time without prior notice.

Subsequent to September 30, 2017, our Board of Directors declared a quarterly dividend of $0.175 per share payable on November 16, 2017 to stockholders of record as of November 6, 2017. Although we intend to continue to pay regular quarterly dividends, the declaration and payment of future dividends are discretionary and will be subject to quarterly determination by our Board of Directors following its review of our financial performance.

We believe that our available capital resources are sufficient to fund our working capital requirements, capital expenditures, income tax obligations and dividends for the foreseeable future.  

Seasonality

Typically, in the weight loss industry, revenue is greatest in the first calendar quarter and weakest in the fourth quarter. We believe our business experiences seasonality, driven primarily by the predisposition of dieters to initiate a diet at certain times of the year and the placement of our advertising, which is based on the price and availability of certain media at such times.  

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We believe that we are not subject to any material risks arising from changes in foreign currency exchange rates, commodity prices, equity prices or other market changes that affect market risk instruments. Our cash and cash equivalents at September 30, 2017 of $47.6 million were maintained in bank and money market funds. Additionally, we invested $42.0 million in short term investments, which are classified as available-for-sale securities and are reported at fair value in the accompanying consolidated balance sheets. A change in interest rates of 1 percentage point would not have a material impact on our operating results and cash flows.

Item 4.

Controls and Procedures

(a)    Evaluation of Disclosure Controls and Procedures. The SEC defines the term “disclosure controls and procedures” to mean a company’s controls and other procedures that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Based on the evaluation of the effectiveness of our disclosure controls and procedures by our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, as of the end of the period covered by this report, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures at the end of the period covered by this report were effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding disclosure.

(b)    Changes in Internal Control Over Financial Reporting. No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended September 30, 2017 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

23


PART II -- OTHER INFORMATION

Item 1.

Legal Proceedings

Litigation

The Company is involved in various claims and routine litigation matters that arise in the ordinary course of business. In the opinion of management, after consultation with legal counsel, the outcomes of such matters are not anticipated to have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows in future years and management believes the range of reasonably possible losses from current matters is immaterial.

Item 1A.

Risk Factors

There have been no material changes to the risk factors disclosed in Part 1, Item 1A in our 2016 Annual Report under the heading “Risk Factors.”  

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Recent Sales of Unregistered Securities

None.

Issuer Purchases of Equity Securities

The following table provides information relating to our purchases of our common stock during the quarter ended September 30, 2017:

 

Period

 

Total Number of Shares Purchased (1) (2)

 

 

Average Price Paid per Share

 

 

Total Number of Shares Purchased as Part of Publicly Announced Plans or Program (1)

 

 

Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Program (1)

 

July 1 - July 31, 2017

 

0

 

 

$

0

 

 

 

0

 

 

$

50,000,000

 

August 1 - August 31, 2017

 

 

3,577

 

 

$

52.33

 

 

 

3,577

 

 

$

49,812,825

 

September 1 - September 30, 2017

 

 

25,098

 

 

$

52.32

 

 

 

25,098

 

 

$

48,499,767

 

 

(1) On May 3, 2016, we announced that our Board of Directors authorized the repurchase of up to $50 million of our outstanding shares of common stock in open-market transactions or otherwise over the next 18-month period. The timing, number and amount of any shares repurchased will be determined by us at our discretion and will be based on a number of factors including our evaluation of general market and economic conditions, the trading price of the common stock, regulatory requirements and compliance with the terms of our outstanding indebtedness. The stock repurchase program may be suspended or discontinued at any time without prior notice.  

 

(2) The period July 1, 2017 through September 30, 2017, does not include 412 shares of common stock, at an average purchase price of $55.92, surrendered by employees to the Company for the payment of tax withholding obligations upon the vesting of shares of restricted stock.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

 

 

24


Item 6.

Exhibits

 

 

 

31.1

 

Certifying Statement of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certifying Statement of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1

 

Certifying Statement of the Chief Executive Officer pursuant to Section 1350 of Title 18 of the United States Code.

 

 

 

32.2

 

Certifying Statement of the Chief Financial Officer pursuant to Section 1350 of Title 18 of the United States Code.

 

 

 

101.INS

 

XBRL Instance Document

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

25


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Nutrisystem, Inc.

 

 

 

 

 

BY:

/S/ Dawn M. Zier

 

 

November 1, 2017      

 

Dawn M. Zier

 

 

President and Chief Executive Officer

 

 

 

BY:

/S/ Michael P. Monahan

 

 

November 1, 2017

 

Michael P. Monahan

 

 

Executive Vice President, Chief Financial Officer and

Principal Accounting Officer

 

 

 

 

 

26